Nuveen Asset Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $617K | Hold |
108,789
| – | – | ﹤0.01% | 2909 |
|
|
2024
Q3 | $636K | Hold |
108,789
| – | – | ﹤0.01% | 2933 |
|
|
2024
Q2 | $861K | Buy |
108,789
+19,424
| +22% | +$154K | ﹤0.01% | 2789 |
|
|
2024
Q1 | $832K | Hold |
89,365
| – | – | ﹤0.01% | 2775 |
|
|
2023
Q4 | $754K | Buy |
89,365
+940
| +1% | +$7.93K | ﹤0.01% | 2850 |
|
|
2023
Q3 | $685K | Hold |
88,425
| – | – | ﹤0.01% | 2731 |
|
|
2023
Q2 | $1.01M | Buy |
+88,425
| New | +$1.01M | ﹤0.01% | 2648 |
|
|
2021
Q2 | – | Sell |
-89,401
| Closed | -$421K | – | 3440 |
|
|
2021
Q1 | $421K | Sell |
89,401
-3,681
| -4% | -$17.3K | ﹤0.01% | 3126 |
|
|
2020
Q4 | $665K | Sell |
93,082
-181,223
| -66% | -$1.29M | ﹤0.01% | 2949 |
|
|
2020
Q3 | $2.93M | Sell |
274,305
-133,134
| -33% | -$1.42M | ﹤0.01% | 2197 |
|
|
2020
Q2 | $5.14M | Sell |
407,439
-7,310
| -2% | -$92.3K | ﹤0.01% | 1883 |
|
|
2020
Q1 | $3.8M | Sell |
414,749
-224
| -0.1% | -$2.05K | ﹤0.01% | 1869 |
|
|
2019
Q4 | $5.79M | Sell |
414,973
-107,086
| -21% | -$1.49M | ﹤0.01% | 1907 |
|
|
2019
Q3 | $8.99M | Buy |
522,059
+264,574
| +103% | +$4.55M | ﹤0.01% | 1643 |
|
|
2019
Q2 | $7.01M | Buy |
+257,485
| New | +$7.01M | ﹤0.01% | 1810 |
|